[1] 万哲,程文敬,彭璐,等. 刺梨抑制氧化应激作用的研究进展[J]. 湖北科技学院学报(医学版),2024 ,38(1):74-78. [2] Bai R, Guo J, Ye XY, et al.Oxidative stress: The core pathogenesis and mechanism of Alzheimer's disease[J]. Ageing Res Rev, 2022, 77: 101619. [3] Forman HJ, Zhang H.Targeting oxidative stress in disease: promise and limitations of antioxidant therapy[J]. Nat Rev Drug Discov, 2021, 20(9): 689-709. [4] 赵佐庆,陈洪茂. 肝癌组织和正常肝组织缺血再灌注损伤的比较研究[J]. 中国普通外科杂志,2005 ,14(7):497-500. [5] Kawamura K, Qi F, Kobayashi J.Potential relationship between the biological effects of low-dose irradiation and mitochondrial ROS production[J]. J Radiat Res, 2018, 59(suppl-2): 91-97. [6] Reiter RJ, Mayo JC, Tan DX, et al.Melatonin as an antioxidant: under promises but over delivers[J]. J Pineal Res, 2016, 61(3): 253-278. [7] Vishnoi S, Raisuddin S, Parvez S.Glutamate Excitotoxicity and Oxidative Stress in Epilepsy: Modulatory Role of Melatonin[J]. J Environ Pathol Toxicol Oncol, 2016, 35(4): 365-374. [8] Nuszkiewicz J, Woźniak A, Szewczyk-Golec K.Ionizing Radiation as a Source of Oxidative Stress-The Protective Role of Melatonin and Vitamin D[J]. Int J Mol Sci, 2020, 21(16): 5804. [9] Batty M, Bennett MR, Yu E.The Role of Oxidative Stress in Atherosclerosis[J]. Cells, 2022, 11(23): 3843. [10] Ahmadian E, Eftekhari A, Kavetskyy T, et al.Effects of quercetin loaded nanostructured lipid carriers on the paraquat-induced toxicity in human lymphocytes[J]. Pestic Biochem Physiol, 2020, 167: 104586. [11] Mahmoudi Z, Kalantar H, Mansouri E, et al.Dimethyl fumarate attenuates paraquat- induced pulmonary oxidative stress, inflammation and fibrosis in mice[J]. Pestic Biochem Physiol, 2023, 190: 105336. [12] Rashidipour M, Rasoulian B, Maleki A, et al.Pectin/chitosan/tripolyphosphate encapsulation protects the rat lung from fibrosis and apoptosis induced by paraquat inhalation[J]. Pestic Biochem Physiol, 2021, 178: 104919. [13] Todd NW, Luzina IG, Atamas SP.Molecular and cellular mechanisms of pulmonary fibrosis[J]. Fibrogenesis Tissue Repair, 2012, 5(1): 11. [14] Amin F, Memarzia A, Kazemi Rad H, et al.Systemic inflammation and oxidative stress induced by inhaled paraquat in rat improved by carvacrol, possible role of PPARγ receptors[J]. Biofactors, 2021, 47(5): 778-787. [15] Kattoor AJ, Pothineni NVK, Palagiri D, et al.Oxidative Stress in Atherosclerosis[J]. Curr Atheroscler Rep, 2017, 19(11): 42. [16] Yang X, Li Y, Li Y, et al.Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies[J]. Front Physiol, 2017, 8: 600. [17] Carey RM, Moran AE, Whelton PK.Treatment of Hypertension: A Review[J]. JAMA, 2022, 328(18): 1849-1861. [18] Kringeland E, Tell GS, Midtbø H, et al.Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study[J]. Eur J Prev Cardiol, 2022, 29(1): 147-154. [19] Franco C, Sciatti E, Favero G, et al.Essential Hypertension and Oxidative Stress: Novel Future Perspectives[J]. Int J Mol Sci, 2022, 23(22): 14489. [20] Korsager Larsen M, Matchkov VV.Hypertension and physical exercise: The role of oxidative stress[J]. Medicina (Kaunas), 2016, 52(1): 19-27. [21] Montezano AC, Touyz RM.Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies[J]. Ann Med, 2012, 44(Suppl): 2-16. [22] Montezano AC, Dulak-Lis M, Tsiropoulou S, et al.Oxidative stress human hypertension: vascular mechanisms, biomarkers, and novel therapies[J]. Can J Cardiol, 2015, 31(5): 631-641. [23] Virdis A, Bacca A, Colucci R, et al.Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation[J]. Hypertension, 2013, 62(2): 337-344. [24] Vanhoutte PM, Shimokawa H, Tang EH, et al.Endothelial dysfunction and vascular disease[J]. Acta Physiol (Oxf), 2009, 196(2): 193-222. [25] Korsager Larsen M, Matchkov VV.Hypertension and physical exercise: The role of oxidative stress[J]. Medicina (Kaunas), 2016, 52(1): 19-27. [26] Hall JE, Granger JP, do Carmo JM, et al. Hypertension: physiology and pathophysiology[J]. Compr Physiol, 2012, 2(4): 2393-2442. [27] Rodrigo R, Prat H, Passalacqua W, et al.Relationship between oxidative stress and essential hypertension[J]. Hypertens Res, 2007, 30(12): 1159-1167. [28] Sun MW, Zhong MF, Gu J, et al.Effects of different levels of exercise volume on endotheliumdependent vasodilation: roles of nitric oxide synthase and heme oxygenase[J]. Hypertens Res, 2008, 31(4): 805-816. [29] Colombo CM, de Macedo RM, Fernandes-Silva MM, et al. Short-term effects of moderate intensity physical activity in patients with metabolic syndrome[J]. Einstein(Sao Paulo), 2013, 11(3): 324-330. [30] Vaziri ND, Ni Z, Oveisi F, et al.Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats[J]. Hypertension, 2000, 36(6): 957-964. [31] Ahmad KA, Yuan D, Nawaz W, et al.Antioxidant therapy for management of oxidative stress induced hypertension[J]. Free Radic Res, 2017, 51(4): 428-438. [32] 麻恒,傅攀峰,邓在春,等. 线粒体相关的慢性阻塞性肺疾病氧化应激机制和抗氧化治疗的研究进展[J]. 现代实用医学,2021,33(12): :1675-1677. [33] Montuschi P, Collins JV, Ciabattoni G, et al.Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers[J]. Am J Respir Crit Care Med, 2000, 162(3 Pt 1): 1175-1177. [34] Rahman I, van Schadewijk AA, Crowther AJ, et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2002, 166(4): 490-495. [35] Rahman I, MacNee W. Antioxidant pharmacological therapies for COPD[J]. Curr Opin Pharmacol, 2012, 12(3): 256-265. [36] Moretti M.Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease[J]. Expert Rev Respir Med, 2007, 1(3): 307-316. [37] Cazzola M, Floriani I, Page CP.The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data[J]. Pulm Pharmacol Ther, 2010, 23(2): 135-144. [38] Dal Negro RW.Erdosteine: antitussive and anti-inflammatory effects[J]. Lung, 2008, 186(Suppl 1): 70-73. [39] Pan Y, Liu T, Wang X, et al.Research progress of coumarins and their derivatives in the treatment of diabetes[J]. J Enzyme Inhib Med Chem, 2022, 37(1): 616-628. [40] Brodsky SV, Gealekman O, Chen J, et al.Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen[J]. Circ Res, 2004, 94(3): 377-384. [41] Xu J, Xie Z, Reece R, et al.Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite[J]. Arterioscler Thromb Vasc Biol, 2006, 26(12): 2688-2695 . [42] Heitzer T, Krohn K, Albers S, et al.Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus[J]. Diabetologia, 2000, 43(11): 1435-1438. [43] Alp NJ, Mussa S, Khoo J, et al.Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression[J]. J Clin Invest, 2003, 112(5): 725-735. [44] Desco MC, Asensi M, Márquez R, et al.Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol[J]. Diabetes, 2002, 51(4): 1118-1124, . [45] Heitzer T, Finckh B, Albers S, et al.Beneficial effects of α-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress[J]. Free Radic Biol Med, 2001, 31(1): 53-61. [46] Ye G, Metreveli NS, Donthi RV, et al.Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes[J]. Diabetes, 2004, 53(5): 1336-1343. [47] Nassar T, Kadery B, Lotan C, et al.Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats[J]. Eur J Pharmacol, 2002, 436(1-2): 111-118 . [48] Huang A, Vita JA, Venema RC, et al.Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin[J]. J Biol Chem, 2000, 275(23): 17399-17406. [49] Mason SA, Parker L, van der Pligt P, et al. Vitamin C supplementation for diabetes management: A comprehensive narrative review[J]. Free Radic Biol Med, 2023, 194: 255-283. [50] Stsiapura VI, Bederman I, Stepuro II, et al.S-Nitrosoglutathione formation at gastric pH is augmented by ascorbic acid and by the antioxidant vitamin complex, Resiston[J]. Pharm Biol, 2018, 56(1): 86-93. [51] Mortensen A, Lykkesfeldt J.Does vitamin C enhance nitric oxide bioavailability in a tetrahydrobiopterin-dependent manner?in vivo and clinical studies[J]. Nitric Oxide, 2014, 36: 51-57. [52] Chen Z, Zhong C.Oxidative stress in Alzheimer’s disease[J]. Neurosci Bull, 2014, 30(2): 271-281. [53] Tholey G, Ledig M.Neuronal and astrocytic plasticity: metabolic aspects[J]. Ann Med Interne (Paris), 1990, 141(Suppl 1): 13-18. [54] Pocernich CB, Butterfield DA.Elevation of glutathione as a therapeutic strategy in Alzheimer disease[J]. Biochim Biophys Acta, 2012, 1822(5): 625-630. [55] Boonruamkaew P, Chonpathompikunlert P, Vong LB, et al.Chronic Treatment with a Smart Antioxidative Nanoparticle for Inhibition of Amyloid Plaque Propagation in Tg2576 Mouse Model of Alzheimer’s Disease[J]. Sci Rep, 2017, 7(1): 3785. [56] El Sayed NS, Ghoneum MH.Antia a Natural Antioxidant Product,Attenuates Cognitive Dysfunction in StreptozotocinInduced Mouse Model of Sporadic Alzheimer’s Disease by Targeting the Amyloidogenic, Inflammatory, Autophagy, and Oxidative Stress Pathways[J]. Oxid Med Cell Longev, 2020: 4386562. [57] Nicolakakis N, Aboulkassim T, Ongali B, et al.Complete Rescue of Cerebrovascular Function in Aged Alzheimer’s Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Agonist[J]. J Neurosci, 2008, 28(37): 9287-9296. [58] Veurink G, Perry G, Singh SK.Role of Antioxidants and a Nutrient Rich Diet in Alzheimer’s Disease[J]. Open Biol, 2020, 10(6): 200084. [59] Mielech A, Pu´scion-Jakubik A, Markiewicz-Zukowska R, et al.Vitamins in Alzheimer’s Disease-Review of the Latest Reports[J]. Nutrients, 2020, 12(11): 3458. [60] Fenech M.Vitamins Associated with Brain Aging, Mild Cognitive Impairment, and Alzheimer Disease: Biomarkers, Epidemiological and Experimental Evidence, Plausible Mechanisms, and Knowledge Gaps[J]. Adv Nutr, 2017, 8(6): 958-970. [61] Sarma BK, Mugesh G, Mugesh G. Glutathione Peroxidase (GPx)-like Antioxidant Activity of the Organoselenium Drug Ebselen: Unexpected Complications with Thiol Exchange Reactions[J]. J Am Chem Soc, 2005, 127(32): 11477-11485. [62] Pearson JK, Boyd RJ.Effect of Substituents on the GPx-like Activity of Ebselen: Steric versus Electronic[J]. J Phys Chem A, 2008, 112(5): 1013-1017. [63] Xie Y, Tan Y, Zheng Y, et al.Ebselen ameliorates β-amyloid pathology,tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice[J]. J Biol Inorg Chem, 2017, 22(6): 851-865. |